Published Time：

2025-04-24

A novel inhaled anti-IL-4Rα monoclonal antibody has been introduced for the treatment of respiratory diseases such as asthma and COPD. The anti-IL-4Rα monoclonal antibody has completed Phase I clinical trials and has begun Phase II clinical trials.

March 2024

November 2023

Quick Navigation

Product

Online Mall

Official WeChat

+86 755-33268688 | Service Hotline

Service Hotline +86 755-33268688

Official WeChat Official Account

Website Construction: www.300.cn

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Corporate Social Responsibility

Published Time：

COOKIES

COOKIES

Sorry，当前栏目暂无内容!

Sorry，The current column has no content!